Icoria’s stock will be delisted from the Nasdaq SmallCap market as of June 30, the biotechnology firm said Thursday morning.

Icoria’s stock failed to meet or exceed the $1 minimum bid price for 180 calendar days. The company said it would not appeal the delisting.

Icoria said its stock will likely be traded on Nasdaq’s Over the Counter Bulleting Board with the symbol ICOR.OB.

The stock was trading at 22 cents early Thursday.

Icoria: www.icoira.com